Antigenics, Inc. (OTCPK: ANTI)
Health Care · Biotechnology · US
$—
— today · — 1Y
Antigenics, Inc. (OTCPK: ANTI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $92.00 and employs 0 people.
trading between 0.00 and 0.00.
ANTI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $92.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 7.12
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.84M
- Employees
- 0
- Next earnings
- —
About Antigenics, Inc.
Antigenics, Inc. operates from its headquarters located in Huntingdon Valley, Pennsylvania.
- ISIN
- US0370311013
- Founded
- 1994
- Listed since
- Aug 24, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.